Windtree Therapeutics Inc Company Profile
Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform produces a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. The companys lead product candidate includes AEROSURF, a drug/device product that combines the proprietary KL4 surfactant and aerosolization technologies, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants. It is also developing aerosolized KL4 surfactant for various respiratory diseases. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was founded in 1992 and is based in Warrington, Pennsylvania.